Literature DB >> 33494858

Deleting Mecp2 from the cerebellum rather than its neuronal subtypes causes a delay in motor learning in mice.

Nathan P Achilly1,2,3, Ling-Jie He1,4,5, Olivia A Kim6, Shogo Ohmae6, Gregory J Wojaczynski6, Tao Lin1,7, Roy V Sillitoe1,2,6,7, Javier F Medina6, Huda Y Zoghbi1,2,5,6,7,8,9.   

Abstract

Rett syndrome is a devastating childhood neurological disorder caused by mutations in MECP2. Of the many symptoms, motor deterioration is a significant problem for patients. In mice, deleting Mecp2 from the cortex or basal ganglia causes motor dysfunction, hypoactivity, and tremor, which are abnormalities observed in patients. Little is known about the function of Mecp2 in the cerebellum, a brain region critical for motor function. Here we show that deleting Mecp2 from the cerebellum, but not from its neuronal subtypes, causes a delay in motor learning that is overcome by additional training. We observed irregular firing rates of Purkinje cells and altered heterochromatin architecture within the cerebellum of knockout mice. These findings demonstrate that the motor deficits present in Rett syndrome arise, in part, from cerebellar dysfunction. For Rett syndrome and other neurodevelopmental disorders, our results highlight the importance of understanding which brain regions contribute to disease phenotypes.
© 2021, Achilly et al.

Entities:  

Keywords:  MeCP2; Rett syndrome; cerebellum; motor learning; mouse; neuroscience

Mesh:

Substances:

Year:  2021        PMID: 33494858      PMCID: PMC7837679          DOI: 10.7554/eLife.64833

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  67 in total

Review 1.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

2.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

3.  Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity.

Authors:  Ling-jie He; Nan Liu; Tian-lin Cheng; Xiao-jing Chen; Yi-ding Li; You-sheng Shu; Zi-long Qiu; Xiao-hui Zhang
Journal:  Nat Commun       Date:  2014-10-09       Impact factor: 14.919

4.  Spatial and Temporal Locomotor Learning in Mouse Cerebellum.

Authors:  Dana M Darmohray; Jovin R Jacobs; Hugo G Marques; Megan R Carey
Journal:  Neuron       Date:  2019-02-19       Impact factor: 17.173

Review 5.  MECP2 disorders: from the clinic to mice and back.

Authors:  Laura Marie Lombardi; Steven Andrew Baker; Huda Yahya Zoghbi
Journal:  J Clin Invest       Date:  2015-08-03       Impact factor: 14.808

6.  Beyond Widespread Mecp2 Deletions to Model Rett Syndrome: Conditional Spatio-Temporal Knockout, Single-Point Mutations and Transgenic Rescue Mice.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  Autism Open Access       Date:  2012

7.  The Synaptic Theory of Memory: A Historical Survey and Reconciliation of Recent Opposition.

Authors:  Jesse J Langille; Richard E Brown
Journal:  Front Syst Neurosci       Date:  2018-10-26

8.  Regulation of autism-relevant behaviors by cerebellar-prefrontal cortical circuits.

Authors:  Elyza Kelly; Fantao Meng; Hirofumi Fujita; Felipe Morgado; Yasaman Kazemi; Laura C Rice; Chongyu Ren; Christine Ochoa Escamilla; Jennifer M Gibson; Sanaz Sajadi; Robert J Pendry; Tommy Tan; Jacob Ellegood; M Albert Basson; Randy D Blakely; Scott V Dindot; Christelle Golzio; Maureen K Hahn; Nicholas Katsanis; Diane M Robins; Jill L Silverman; Karun K Singh; Rachel Wevrick; Margot J Taylor; Christopher Hammill; Evdokia Anagnostou; Brad E Pfeiffer; Catherine J Stoodley; Jason P Lerch; Sascha du Lac; Peter T Tsai
Journal:  Nat Neurosci       Date:  2020-07-13       Impact factor: 24.884

9.  Developmental delay in Rett syndrome: data from the natural history study.

Authors:  Jeffrey L Neul; Jane B Lane; Hye-Seung Lee; Suzanne Geerts; Judy O Barrish; Fran Annese; Lauren McNair Baggett; Katherine Barnes; Steven A Skinner; Kathleen J Motil; Daniel G Glaze; Walter E Kaufmann; Alan K Percy
Journal:  J Neurodev Disord       Date:  2014-07-22       Impact factor: 4.025

10.  Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome.

Authors:  Kiran Girdhar; Gabriel E Hoffman; Yan Jiang; Leanne Brown; Marija Kundakovic; Mads E Hauberg; Nancy J Francoeur; Ying-Chih Wang; Hardik Shah; David H Kavanagh; Elizabeth Zharovsky; Rivka Jacobov; Jennifer R Wiseman; Royce Park; Jessica S Johnson; Bibi S Kassim; Laura Sloofman; Eugenio Mattei; Zhiping Weng; Solveig K Sieberts; Mette A Peters; Brent T Harris; Barbara K Lipska; Pamela Sklar; Panos Roussos; Schahram Akbarian
Journal:  Nat Neurosci       Date:  2018-07-23       Impact factor: 24.884

View more
  4 in total

1.  MeCP2 loss-of-function dysregulates microRNAs regionally and disrupts excitatory/inhibitory synaptic transmission balance.

Authors:  Patricia M Horvath; Michelle K Piazza; Ege T Kavalali; Lisa M Monteggia
Journal:  Hippocampus       Date:  2022-07-19       Impact factor: 3.753

2.  P-sort: an open-source software for cerebellar neurophysiology.

Authors:  Ehsan Sedaghat-Nejad; Mohammad Amin Fakharian; Jay Pi; Paul Hage; Yoshiko Kojima; Robi Soetedjo; Shogo Ohmae; Javier F Medina; Reza Shadmehr
Journal:  J Neurophysiol       Date:  2021-08-25       Impact factor: 2.974

Review 3.  Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated clinical considerations.

Authors:  Jatinder Singh; Evamaria Lanzarini; Nardo Nardocci; Paramala Santosh
Journal:  Psychiatry Clin Neurosci       Date:  2021-10-21       Impact factor: 12.145

Review 4.  The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models.

Authors:  Lisa Mapelli; Teresa Soda; Egidio D'Angelo; Francesca Prestori
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.